Correlation of MYC rearrangement with MYC immunohistochemistry in aggressive B-cell lymphomas Read more about Correlation of MYC rearrangement with MYC immunohistochemistry in aggressive B-cell lymphomas
Aggressive B-cell lymphomas of the respiratory system: histologic, immunohistochemical and genetic evaluation of a large series Read more about Aggressive B-cell lymphomas of the respiratory system: histologic, immunohistochemical and genetic evaluation of a large series
Aggressive B-cell lymphoma in extreme age groups; Review of a series of 760 cases Read more about Aggressive B-cell lymphoma in extreme age groups; Review of a series of 760 cases
MultiOmyx™ multiplexed tumor infiltrating lymphocyte panel provides comprehensive immunophenotyping from a single FFPE slide Read more about MultiOmyx™ multiplexed tumor infiltrating lymphocyte panel provides comprehensive immunophenotyping from a single FFPE slide
Detection of IFNγ induced PD-L1 expression by combined in situ RNA analysis and protein profiling from a single FFPE slide Read more about Detection of IFNγ induced PD-L1 expression by combined in situ RNA analysis and protein profiling from a single FFPE slide
PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer Read more about PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer
MLL: The gene and its translocation partners. 2 cases with a t(11;17) involving MLL and mimicking the variant t(11;17) RARA translocation Read more about MLL: The gene and its translocation partners. 2 cases with a t(11;17) involving MLL and mimicking the variant t(11;17) RARA translocation
Using next generation sequencing of peripheral blood cfDNA as a clinical test in screening for hematologic neoplasms Read more about Using next generation sequencing of peripheral blood cfDNA as a clinical test in screening for hematologic neoplasms
Interclonal and intraclonal heterogeneity in patients with IDH1/2 mutation Read more about Interclonal and intraclonal heterogeneity in patients with IDH1/2 mutation
Higher mutation rate in patients with aplastic anemia using peripheral blood cfDNA as compared with bone marrow cells Read more about Higher mutation rate in patients with aplastic anemia using peripheral blood cfDNA as compared with bone marrow cells